FirstWord

Biosimilars: US Payer Insights 2020

New 2020 Report

From $3,295.00

COVID-19 Implications for pharma: US payer insights

New June 2020 Report

From $1,195.00

Trends in Digital Physician Engagement

April 2020 New Report

From $3,295.00

The Future of CRISPR

From $445.00

Paying for Digital Health: Payer Insights

October 2018

From $2,495.00

Benchmarking Pharma's MSL Capabilities

October 2018

From $2,495.00

Succeeding with value based contracts

October 2018

From $2,495.00

Pricing and Reimbursement in Neurology

October 2018

From $2,375.00

Bladder Cancer: KOL Insight [2018]

September 2018

From $8,495.00

Biosimilars in Emerging Markets (2018)

September 2018

From $2,495.00

Breast Cancer: KOL Insight [2018]

June 2018

From $8,495.00

The Future of Market Access in the US

April 2018

From $2,375.00

The Future of Medical Affairs

January 2017

From $695.00

Measuring Marketing Channel Effectiveness

November 2016

From $695.00

The Future of Orphan Drugs

November 2016

From $695.00

Digital Health Startups

November 2016

From $695.00

Report Topics